Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
54 studies found for:    Northwestern AND Metabolic bone disease
Show Display Options
Rank Status Study
1 Recruiting Prevention of Bone Loss After Acute SCI by Zoledronic Acid
Conditions: Spinal Cord Injury;   Acute Spinal Cord Injury;   Bone Loss;   Osteoporosis
Interventions: Drug: Zoledronic acid;   Drug: Placebo
2 Active, not recruiting 12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
Conditions: Spinal Cord Injury;   Bone Loss;   Osteoporosis
Interventions: Drug: Teriparatide;   Device: Vibration
3 Enrolling by invitation Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury Previously Treated With Teriparatide
Conditions: Spinal Cord Injury;   Bone Loss;   Osteoporosis
Interventions: Drug: Alendronate;   Dietary Supplement: Calcium;   Dietary Supplement: Vitamin D
4 Completed
Has Results
Head to Head Study Against Sevelamer Hydrochloride
Condition: Chronic Kidney Disease, Stage 5
Interventions: Drug: Fosrenol (Lanthanum Carbonate);   Drug: Sevelamer hydrochloride
5 Terminated Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum Carbonate
Condition: Chronic Kidney Failure
Interventions: Drug: Magnesium iron hydroxycarbonate;   Drug: Lanthanum carbonate;   Drug: Placebo
6 Terminated
Has Results
The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5
Conditions: Chronic Kidney Disease (CKD) Stage 5;   Hypertrophy, Left Ventricular
Interventions: Drug: paricalcitol injection 4 mcg/mL;   Drug: Placebo Injection 4 mcg/mL
7 Completed Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency (28-week Extension Study)
Conditions: Diabetes Mellitus, Type 2;   Renal Insufficiency
Interventions: Drug: vildagliptin;   Drug: sitagliptin
8 Completed Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: vildagliptin;   Drug: Sitagliptin
9 Recruiting Evaluation of the Effects of Canagliflozin on Renal and Cardiovascular Outcomes in Participants With Diabetic Nephropathy
Conditions: Diabetes Mellitus, Type 2;   Diabetic Nephropathy
Interventions: Drug: Canagliflozin;   Drug: Placebo
10 Terminated
Has Results
Efficacy and Safety of Zoledronic Acid in Acute Spinal Cord Injury: Prevention of Bone Loss
Condition: Bone Loss
Interventions: Drug: zoledronic acid;   Drug: placebo
11 Completed Efficacy and Safety of Lanthanum Carbonate in Reducing Serum Phosphorus Levels in Subjects With Stage 3 and 4 Chronic Kidney Disease
Condition: Kidney Diseases
Interventions: Drug: Lanthanum carbonate;   Drug: Placebo
12 Withdrawn Pharmacogenomics of Methadone in Spine Fusion Surgery
Conditions: Scoliosis;   Kyphosis
Intervention: Drug: Methadone
13 Completed Osteoporosis Research Registry
Condition: Osteoporosis
Intervention:
14 Completed Improving Care of Osteoporosis: Multi-Modal Intervention to Increase Testing and Treatment (ICOMMIITT)
Condition: Osteoporosis
Interventions: Behavioral: Patient educational DVD and brochure;   Behavioral: Physician web modules;   Behavioral: System
15 Completed Tamoxifen to Prevent Bone Loss and Heart Disease in Premenopausal Women Receiving Chemotherapy for Stage I or Stage II Breast Cancer
Conditions: Breast Cancer;   Osteoporosis
Intervention:
16 Terminated Effect of Vitamin D Supplementation on In-vitro Fertilization (IVF) Outcomes
Conditions: Infertility;   Vitamin D Deficiency
Intervention:
17 Active, not recruiting Effect of Teriparatide, Vibration and the Combination on Bone Mass and Bone Architecture in Chronic Spinal Cord Injury
Conditions: Spinal Cord Injury;   Bone Loss;   Osteoporosis
Interventions: Drug: Teriparatide;   Device: vibration
18 Active, not recruiting Zolendronate for the Prevention of Bone Loss in Men w/ Prostate CA on Long-Term Androgen Deprivation
Conditions: Osteoporosis;   Prostate Cancer
Interventions: Dietary Supplement: cholecalciferol;   Drug: calcium gluconate;   Drug: zoledronic acid
19 Completed
Has Results
Effect of Parathyroid Hormone (PTH) and Weight-Bearing on Bone in Spinal Cord Injury (SCI)
Conditions: Osteoporosis;   Bone Loss;   Spinal Cord Injury
Interventions: Drug: teriparatide;   Other: weight-bearing
20 Recruiting Comparison of Oral Octreotide Capsules to Injectable Somatostatin Analogs in Acromegaly
Condition: Acromegaly
Interventions: Drug: Octreotide capsules;   Drug: Injectable Somatostatin Analogs (octreotide or lanreotide);   Drug: Cabergoline

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.